MedTrace Logo

Clinical Investigation of Refraction Techniques

NCT05461586 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2023-01-06

No results posted yet for this study

Summary

Prospective, multi-center, non-interventional, randomized, comparative clinical study to identify an optimal refractive technique that provides maximum plus refractive endpoint for best corrected distance visual acuity (BCDVA).

Conditions

  • Refractive Error

Interventions

DEVICE

Refractive Technique (MR #1)

Fogging method that employs fogging lens to ensure there is sufficient visual defocus to induce blur.

DEVICE

Refractive Technique (MR #2)

Duochrome method that employs the chromatic aberration of the eye, with the shorter wavelengths (green) focused in front of the longer (red) wavelengths

Sponsors & Collaborators

  • Johnson & Johnson Surgical Vision, Inc.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Surgical Vision, Inc. Clinical Trial · Johnson & Johnson Surgical Vision, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-14
Primary Completion
2022-08-09
Completion
2022-08-09

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05461586 on ClinicalTrials.gov